Advertisement

Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Australia’s post-Bondi crackdown accused of targeting pro-Palestinian voices - 2
I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works. - 3
Scaling New Levels: Rock Climbing Spots On the planet - 4
Australians told to continue Easter travel plans despite fuel shortages - 5
Vote In favor of Your Favored Keeping an eye on
What exactly is the Upside Down in 'Stranger Things'? The wormhole revelation, explained.
Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
Pick Your Favored kind of sandwich
Police break up illegal chicken slaughter in Germany
Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
At least 11 killed in South Africa mass shooting
Artemis 2 moon astronauts will try to recreate Apollo 8's historic 'Earthrise' photo during April 6 flyby
Investigating Free Cell Phones: What You Really want to Be aware
EU delays signing of Mercosur free trade deal












